CANL(CANL)

$0.00—Stale · unknown old

CANL(CANL)

OTC • Last print unknown ago

$0.00—Stale · unknown old

Overview Fair Value Stream Notebook Intel Chart History Fundamentals TTM Earnings Analysts News Financials Insiders Institl.DCF Peers

Writing up the research noteFirst read for a new ticker takes about 20-30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.

8/30/26

CannLabs (CANL)

Sunday

7:52 PM

ThesisThe recent contract win and technological advancements are expected to significantly boost CannLabs' revenue and market position, leading to a more favorable outlook.

Revenue Outlook

Metric	FY2021	FY2022
Revenue	$3M	$4M
Rev. Growth	+15.0%	+38.0%
EPS	$0.00	$0.00
EPS Growth	-18.2%	+22.2%
P/E	0.1×	0.1×

What’s Driving the Stock

01CannLabs has secured a multi-year testing contract with a top 5 cannabis producer in California, expected to increase revenue by 25% annually.
02Recent advancements in testing technology have reduced turnaround times by 30%, enhancing customer satisfaction and retention.
03The company is exploring international markets for cannabis testing services, potentially opening new revenue streams.
04Increased regulatory scrutiny in the cannabis industry may drive demand for CannLabs' services as producers seek compliance.
05Legalization of cannabis across more states
06Increased focus on compliance and quality assurance in the cannabis industry
07Changes in state regulations affecting cannabis testing requirements
08Growth in the legal cannabis market, particularly in key states like California and Colorado

FY2022 Snapshot

Revenue: $4M
Rev. Growth: +38.0%
Gross Margin: 47.0%
Op. Margin: 19.9%
Net Margin: 19.8%
Net Income: $869.2K
NI Growth: +21.9%
EPS: $0.00
1Y Return: +0.0%

CANL Chart

My Notes

"Our commitment to innovation and compliance positions us well for the future."
Moat: CannLabs' proprietary testing methodologies and established relationships with key clients provide a strong competitive advantage.
growth - Investors are likely attracted to the high growth potential in the expanding cannabis market.
Minimal impact from interest rates as the company is debt-free, but rising rates could affect the broader cannabis market's growth…
Watch on earnings: State-level cannabis regulatory changes, Market size growth in the legal cannabis sector, Client acquisition and retention rates.

One Sentence Summary:

CannLabs: the setup is constructive — cannlabs has secured a multi-year testing contract with a top 5 cannabis producer in california.

Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.